Back to Search
Start Over
Efficacy and Safety Results of a Phase 1 Study of 177lu-DOTA-HH1 (Betalutin®) with and without HH1 Pre-Dosing for Patients with Relapsed CD37+ Non-Hodgkin B Cell Lymphoma (NHL)
- Source :
- Blood; December 2015, Vol. 126 Issue: 23 p5118-5118, 1p
- Publication Year :
- 2015
-
Abstract
- Background:
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 126
- Issue :
- 23
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs56868977
- Full Text :
- https://doi.org/10.1182/blood.V126.23.5118.5118